Abstract
Purpose
Hyaluronan mediates growth of SW620 colon cancer cells. Because hyaluronan is the active ingredient in Seprafilm®, we hypothesized that Seprafilm® would affect intraperitoneal tumor growth in a mouse model of peritoneal seeding.
Methods
Immunodeficient mice underwent laparotomy and intraperitoneal inoculation of 105 SW620 cells. Seprafilm® (n = 22), Vicryl mesh (foreign body control; n = 24), or no material (sham; n = 19) was placed under the incision. Mice were killed after four weeks and tumors were dissected, counted, and weighed.
Results
Ninety-five percent of mice in the sham group and 96 percent in the Vicryl group developed intraperitoneal tumors. In contrast, only 64 percent of mice in the Seprafilm® group developed tumors (P = 0.024), and these tumors were smaller than those in the sham group; (Seprafilm® = 42 ± 9 mg vs. sham = 82 ± 17 mg; P = 0.05). In contrast, tumors in the Vicryl group were dramatically larger (349 ± 49 mg; P < 0.001 vs. sham or Seprafilm®).
Conclusions
Despite previous data that suggested that hyaluronan increases colon cancer cell growth, we found that Seprafilm® decreased tumor formation and tended to decrease size in this model. In contrast, Vicryl mesh increased tumor formation and size. Our results suggest that Seprafilm® does not promote intraperitoneal tumor growth, especially compared with Vicryl mesh.
Similar content being viewed by others
References
Rodier JF, Janser JC, Delahaye JF, Rodier D. Use of polyglactin 910 mesh (Vicryl) in pelvic oncologic surgery. Adv Ther 1992;9:233–9.
Dasmahapatra KS, Swaminathan AP. The use of a biodegradable mesh to prevent radiation-associated small-bowel injury. Arch Surg 1991;126:366–9.
Hoffman MS, Roberts WS, LaPolla JP, Fiorica JV, Cavanagh D. Use of Vicryl mesh in the reconstruction of the pelvic floor following exenteration. Gynecol Oncol 1989;35:170–1.
Menzel EJ, Farr C. Hyaluronidase and its substrate hyaluronan: biochemistry, biological activities and therapeutic uses. Cancer Lett 1998;131:3–11.
West DC, Kumar S. The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp Cell Res 1989;183:179–96.
Arai H, Kang KY, Sato H, et al. Significance of the quantification and demonstration of hyaluronic acid in tissue specimens for the diagnosis of pleural mesothelioma. Am Rev Resp Dis 1979;120:529–32.
Hopwood JJ, Dorfman A. Glycosaminoglycan synthesis by Wilms’ tumor. Pediatr Res 1978;12:52–6.
Auvinen PK, Parkkinen JJ, Johansson RT, et al. Expression of hyaluronan in benign and malignant breast lesions. Int J Cancer 1997;74:477–81.
Auvinen P, Tammi R, Parkkinen J, et al. Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol 2000;156:529–36.
Setala LP, Tammi MI, Tammi RH, et al. Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate. Br J Cancer 1999;79:1133–8.
Lovvorn HN 3rd, Savani RC, Ruchelli E, Cass DL, Adzick NS. Serum hyaluronan and its association with unfavorable histology and aggressiveness of heterotransplanted Wilms’ tumor. J Pediatr Surg 2000;35:1070–8.
Wang C, Tammi M, Guo H, Tammi R. Hyaluronan distribution in the normal epithelium of esophagus, stomach, and colon and their cancers. Am J Pathol 1996;148:1861–9.
Paiva P, Van Damme MP, Tellbach M, Jones RL, Jobling T, Salamonsen LA. Expression patterns of hyaluronan, hyaluronan synthases and hyaluronidases indicate a role for hyaluronan in the progression of endometrial cancer. Gynecol Oncol 2005;98:193–202.
Ropponen K, Tammi M, Parkkinen J, et al. Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res 1998;58:342–7.
Li Y, Heldin P. Hyaluronan production increases the malignant properties of mesothelioma cells. Br J Cancer 2001;85:600–7.
Bullard KM, Kim HR, Wheeler MA, et al. Hyaluronan synthase-3 is upregulated in metastatic colon carcinoma cells and manipulation of expression alters matrix retention and cellular growth. Int J Cancer 2003;107:739–46.
Kim HR, Wheeler MA, Wilson CM, et al. Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44. Cancer Res 2004;64:4569–76.
Wilson CM, Wheeler MA, McCarthy JB, et al. Hyaluronan increases colon carcinoma cell growth in vitro. Dis Colon Rectum 2005;48:606.
Deutsch AA, Stern HS. Technique of insertion of pelvic Vicryl mesh sling to avoid post radiation enteritis. Dis Colon Rectum 1989;32:628–30.
Soper JT, Clarke-Pearson DL, Creasman WT. Absorbable synthetic mesh (910-polyglactin) intestinal sling to reduce radiation-induced small bowel injury in patients with pelvic malignancies. Gynecol Oncol 1988;29:283–9.
Clarke-Pearson DL, Soper JT, Creasman WT. Absorbable synthetic mesh (polyglactin 910) for the formation of a pelvic “lid” after radical pelvic resection. Am J Obstet Gynecol 1988;158:158–61.
Kusunoki M, Ikeuchi H, Yanagi H, et al. Bioresorbable hyaluronate-carboxymethylcellulose membrane (Seprafilm® in surgery for rectal carcinoma: a prospective randomized clinical trial. Surg Today 2005;35:940–5.
Oikonomakis I, Wexner SD, Gervaz P, You SY, Secic M, Giamundo P. Seprafilm®: a retrospective preliminary evaluation of the impact on short-term oncologic outcome in colorectal cancer. Dis Colon Rectum 2002;45:1376–80.
Hubbard SC, Burns JW. Effects of a hyaluronan-based membrane (Seprafilm®) on intraperitoneally disseminated human colon cancer cell growth in a nude mouse model. Dis Colon Rectum 2002;45:334–44.
Pucciarelli S, Codello L, Rosato A, Del Bianco P, Vecchiato G, Lise M. Effect of antiadhesive agents on peritoneal carcinomatosis in an experimental model. Br J Surg 2003;90:66–71.
Gago LA, Saed GM, Chauhan S, Elhammady EF, Diamond MP. Seprafilm® (modified hyaluronic acid and carboxymethylcellulose) acts as a physical barrier. Fertil Steril 2003;80:612–6.
Tarhan OR, Eroglu A, Cetin R, Y Nce A, Bulbul M, Altuntas YR. Effects of Seprafilm® on peritoneal fibrinolytic system. ANZ J Surg 2005;75:690–2.
Ghatak S, Misra S, Toole BP. Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J Biol Chem 2002;277:38013–20.
Gencosmanoglu R, Asoglu O, Bugra D, Bulut T, Cevikbas U, Yamaner S. The impact of various suture materials on experimental colorectal carcinogenesis. Surg Today 2001;31:215–21.
McCue JL, Sheffield JP, Uff C, Phillips RK. Experimental carcinogenesis at sutured and sutureless colonic anastomoses. Dis Colon Rectum 1992;35:902–9.
Kyzer S, Gordon PH. Proliferative activity at rectal anastomoses performed with various suture materials. An experimental study. Dis Colon Rectum 1995;38:1026–32.
McCue JL, Phillips RK. Cellular proliferation at sutured and sutureless colonic anastomoses. Dis Colon Rectum 1993;36:468–74.
O'Dwyer P, Ravikumar TS, Steele G Jr. Serum dependent variability in the adherence of tumour cells to surgical sutures. Br J Surg 1985;72:466–9.
ACKNOWLEDGMENTS
Author information
Authors and Affiliations
Corresponding author
Additional information
Reprints are not available.
About this article
Cite this article
Lee, P.K., Windsperger, A.P., Wilson, C.M. et al. The Effect of a Hyaluronan-Carboxymethylcellulose Membrane vs. Polyglactin 910 Mesh on Intra-Abdominal Tumor Formation in Mice. Dis Colon Rectum 51, 1403–1407 (2008). https://doi.org/10.1007/s10350-008-9299-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10350-008-9299-z